🇺🇸 FDA
Pipeline program

cyclophosphamide

CDR0000078385

Phase 3 small_molecule completed

Quick answer

cyclophosphamide for Breast Cancer is a Phase 3 program (small_molecule) at Partner Therapeutics Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Partner Therapeutics Limited
Indication
Breast Cancer
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials